Stem Cell Therapies for Intraocular Disease

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Irreversible blindness resulting from retinal or optic nerve diseases continues to devastate patients. The use of stem cell technology to reverse blindness promises great individual and societal benefit. Stem cell therapies seek to replace or enhance the function of damaged tissues. Currently, there are no FDA approved and commercially available products in this arena. Numerous clinical trials are underway, but as of today, we are still awaiting rigorous study data. Meanwhile, physicians and patients are desperate to restore vision and are lured to clinics claiming success. It remains our duty to vet these claims and guide our patients with their best interests in mind.

Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalMissouri Medicine
Issue number1
StatePublished - Jan 1 2022


Dive into the research topics of 'Stem Cell Therapies for Intraocular Disease'. Together they form a unique fingerprint.

Cite this